• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Thursday

    7/6/23 12:58:38 PM ET
    $VRAY
    $WIA
    $WIW
    $XNCR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Trusts Except Educational Religious and Charitable
    Finance
    Get the next $VRAY alert in real time by email

     

    On Thursday, 109 companies set new 52-week lows.

    52-Week Low Highlights:

    • The largest company in terms of market cap to set a new 52-week low was Nasdaq (NASDAQ:NDAQ).
    • Biodexa Pharmaceuticals (NASDAQ:BDRX) was the smallest company in terms of market cap to set a new 52-week low.
    • Sarcos Technology (NASDAQ:STRC) shares dropped the most, trading down 417.35% to reach its new 52-week low.
    • Cineverse (NASDAQ:CNVS) shares were the most resilient, as shares rose 0.0%, rebounding from its new 52-week low.

    Here is a list of stocks that set new 52-week lows on Thursday:

    • Nasdaq (NASDAQ:NDAQ) stock achieved a new 52-week low on Thursday morning, hitting $48.90 and moving down 1.92%.
    • Jazz Pharmaceuticals (NASDAQ:JAZZ) shares were down 2.02% for the day, having made a 52-week low of $120.81.
    • Repligen (NASDAQ:RGEN) shares reached a new 52-week low of $134.64 on Thursday morning, moving up 0.06%.
    • UGI (NYSE:UGI) shares set a new 52-week low of $26.30. The stock traded down 1.59%.
    • Prosperity Bancshares (NYSE:PB) shares set a new yearly low of $54.73 this morning. The stock was down 2.15% on the session.
    • Tower Semiconductor (NASDAQ:TSEM) shares set a new yearly low of $35.57 this morning. The stock was down 2.24% on the session.
    • Clearway Energy (NYSE:CWEN) stock dropped to a yearly low on Thursday of $27.55. Shares traded down 3.5%.
    • UniFirst (NYSE:UNF) stock hit $150.50 on Thursday morning, setting a new 52-week low for a change of down 0.24%.
    • Atlantica Sustainable (NASDAQ:AY) shares fell to $22.64 on Thursday, setting a new 52-week low with a shift of down 2.94%.
    • Servisfirst Bancshares (NYSE:SFBS) shares made a new 52-week low of $39.27 on Thursday. The stock was down 3.05% for the day.
    • SunPower (NASDAQ:SPWR) stock set a new 52-week low of $9.06 on Thursday, moving down 5.94%.
    • Adtalem Glb Education (NYSE:ATGE) shares moved down 1.14% on Thursday to hit a new 52-week low of $33.59, drifting down 1.14%.
    • Duckhorn Portfolio (NYSE:NAPA) shares were up 0.04% for the day, having made a 52-week low of $12.55.
    • Xencor (NASDAQ:XNCR) stock hit $23.63 on Thursday morning, setting a new 52-week low for a change of down 2.58%.
    • BioCryst Pharma (NASDAQ:BCRX) shares fell to $6.82 on Thursday, setting a new 52-week low with a shift of down 2.7%.
    • Fiverr Intl (NYSE:FVRR) shares made a new 52-week low of $24.69 on Thursday. The stock was down 6.44% for the day.
    • Dine Brands Global (NYSE:DIN) stock hit $56.00 on Thursday morning, setting a new 52-week low for a change of down 0.9%.
    • Southside Bancshares (NASDAQ:SBSI) shares reached a new 52-week low of $25.39 on Thursday morning, moving down 3.5%.
    • Mativ Holdings (NYSE:MATV) shares were down 4.47% for the day, having made a 52-week low of $13.92.
    • SunOpta (NASDAQ:STKL) stock hit a yearly low of $6.22. The stock was down 4.88% for the day.
    • James River Gr Hldgs (NASDAQ:JRVR) shares hit a yearly low of $17.21. The stock was down 2.41% on the session.
    • American Well (NYSE:AMWL) shares fell to $1.92 on Thursday, setting a new 52-week low with a shift of down 1.72%.
    • Western Asset (NYSE:WIW) shares reached a new 52-week low of $8.79 on Thursday morning, moving down 0.68%.
    • Intchains Gr (NASDAQ:ICG) stock set a new 52-week low of $6.48 on Thursday, moving up 1.07%.
    • Sohu.com (NASDAQ:SOHU) shares were down 0.73% for the day, having made a 52-week low of $10.86.
    • Emergent BioSolutions (NYSE:EBS) shares hit a yearly low of $6.77. The stock was down 7.07% on the session.
    • SIGA Technologies (NASDAQ:SIGA) shares were down 2.74% for the day, having made a 52-week low of $4.73.
    • 2U (NASDAQ:TWOU) shares moved down 8.71% on Thursday to hit a new 52-week low of $3.35, drifting down 8.71%.
    • SoundThinking (NASDAQ:SSTI) stock set a new 52-week low of $20.58 on Thursday, moving down 1.31%.
    • Nutex Health (NASDAQ:NUTX) shares reached a new 52-week low of $0.38 on Thursday morning, moving down 8.14%.
    • I-MAB (NASDAQ:IMAB) shares set a new yearly low of $2.61 this morning. The stock was down 7.02% on the session.
    • Western Asset Inflation (NYSE:WIA) shares were down 0.6% for the day, having made a 52-week low of $8.23.
    • Nuveen Virginia Quality (NYSE:NPV) shares reached a new 52-week low of $10.61 on Thursday morning, moving down 1.39%.
    • Vor Biopharma (NASDAQ:VOR) stock broke to a new 52-week low of $2.63 on Thursday. Shares of the company traded down 5.15%.
    • Nouveau Monde Graphite (NYSE:NMG) shares made a new 52-week low of $2.93 on Thursday. The stock was down 2.02% for the day.
    • NanoString Technologies (NASDAQ:NSTG) shares set a new 52-week low of $3.65. The stock traded down 5.05%.
    • Karyopharm Therapeutics (NASDAQ:KPTI) shares were down 8.79% for the day, having made a 52-week low of $1.50.
    • Altimmune (NASDAQ:ALT) stock hit a yearly low of $3.20. The stock was down 4.26% for the day.
    • ClearPoint Neuro (NASDAQ:CLPT) shares made a new 52-week low of $6.37 on Thursday. The stock was down 4.75% for the day.
    • Ames National (NASDAQ:ATLO) shares fell to $17.51 on Thursday, setting a new 52-week low with a shift of down 2.07%.
    • Aadi Bioscience (NASDAQ:AADI) stock drifted down 6.09% on Thursday morning to hit a new 52-week low of $6.11.
    • Cara Therapeutics (NASDAQ:CARA) shares hit a yearly low of $2.60. The stock was down 7.87% on the session.
    • Noodles (NASDAQ:NDLS) shares made a new 52-week low of $3.02 on Thursday. The stock was down 3.33% for the day.
    • Hurco Cos (NASDAQ:HURC) shares made a new 52-week low of $20.56 on Thursday. The stock was down 1.96% for the day.
    • Delaware Inv Natl Muni (AMEX:VFL) shares set a new 52-week low of $9.87. The stock traded down 1.1%.
    • Stereotaxis (AMEX:STXS) stock hit a new 52-week low of $1.43. The stock was down 3.36% on the session.
    • Cherry Hill Mortgage (NYSE:CHMI) stock set a new 52-week low of $4.42 on Thursday, moving down 4.16%.
    • BP Prudhoe Bay (NYSE:BPT) stock set a new 52-week low of $4.52 on Thursday, moving down 5.41%.
    • Nkarta (NASDAQ:NKTX) stock set a new 52-week low of $1.91 on Thursday, moving down 8.77%.
    • Intevac (NASDAQ:IVAC) stock set a new 52-week low of $3.47 on Thursday, moving down 3.34%.
    • Rite Aid (NYSE:RAD) stock achieved a new 52-week low on Thursday morning, hitting $1.42 and moving down 0.07%.
    • Intercure (NASDAQ:INCR) stock achieved a new 52-week low on Thursday morning, hitting $1.52 and moving down 1.77%.
    • Ohmyhome (NASDAQ:OMH) stock achieved a new 52-week low on Thursday morning, hitting $3.61 and moving down 4.47%.
    • comScore (NASDAQ:SCOR) stock broke to a new 52-week low of $0.71 on Thursday. Shares of the company traded down 8.73%.
    • Near Intelligence (NASDAQ:NIR) stock hit a yearly low of $1.17. The stock was down 9.02% for the day.
    • Meihua Intl Medical Techs (NASDAQ:MHUA) shares were down 3.52% for the day, having made a 52-week low of $2.54.
    • ViewRay (NASDAQ:VRAY) stock achieved a new 52-week low on Thursday morning, hitting $0.33 and moving down 6.25%.
    • Airgain (NASDAQ:AIRG) shares set a new yearly low of $4.90 this morning. The stock was down 0.79% on the session.
    • Gold Resource (AMEX:GORO) shares hit a yearly low of $0.54. The stock was down 10.66% on the session.
    • 22nd Century Group (NASDAQ:XXII) stock broke to a new 52-week low of $2.68 on Thursday. Shares of the company traded down 23.94%.
    • PhenomeX (NASDAQ:CELL) shares set a new 52-week low of $0.43. The stock traded down 6.16%.
    • Destra Multi-Alternative (NYSE:DMA) stock dropped to a yearly low on Thursday of $4.93. Shares traded down 1.7%.
    • Sarcos Technology (NASDAQ:STRC) shares hit a yearly low of $1.62. The stock was up 417.35% on the session.
    • BEST (NYSE:BEST) stock drifted down 6.54% on Thursday morning to hit a new 52-week low of $1.95.
    • Koss (NASDAQ:KOSS) shares fell to $3.40 on Thursday, setting a new 52-week low with a shift of down 4.12%.
    • Yunji (NASDAQ:YJ) stock hit $1.47 on Thursday morning, setting a new 52-week low for a change of down 6.96%.
    • Psychemedics (NASDAQ:PMD) shares moved down 0.45% on Thursday to hit a new 52-week low of $4.38, drifting down 0.45%.
    • MSP Recovery (NASDAQ:LIFW) shares set a new 52-week low of $0.28. The stock traded down 3.94%.
    • Phoenix New Media (NYSE:FENG) shares hit a yearly low of $1.80. The stock was down 5.76% on the session.
    • Tattooed Chef (NASDAQ:TTCF) shares set a new yearly low of $0.25 this morning. The stock was down 12.53% on the session.
    • Capstone Green Energy (NASDAQ:CGRN) shares moved down 3.81% on Thursday to hit a new 52-week low of $1.06, drifting down 3.81%.
    • Nuburu (AMEX:BURU) shares hit a yearly low of $0.45. The stock was down 11.31% on the session.
    • Cineverse (NASDAQ:CNVS) shares made a new 52-week low of $1.66 on Thursday. The stock was 0.0% (flat) for the day.
    • Treasure Global (NASDAQ:TGL) stock achieved a new 52-week low on Thursday morning, hitting $0.98 and moving up 1.71%.
    • Addentax Group (NASDAQ:ATXG) shares made a new 52-week low of $4.16 on Thursday. The stock was down 7.32% for the day.
    • Akumin (NASDAQ:AKU) shares set a new yearly low of $0.16 this morning. The stock was down 6.13% on the session.
    • Nogin (NASDAQ:NOGN) stock dropped to a yearly low on Thursday of $1.04. Shares traded down 13.6%.
    • Carver Bancorp (NASDAQ:CARV) shares moved down 0.95% on Thursday to hit a new 52-week low of $2.57, drifting down 0.95%.
    • Pop Culture Gr (NASDAQ:CPOP) stock hit a yearly low of $0.40. The stock was down 2.06% for the day.
    • Monopar Therapeutics (NASDAQ:MNPR) stock hit $0.80 on Thursday morning, setting a new 52-week low for a change of up 3.43%.
    • VBI Vaccines (NASDAQ:VBIV) stock broke to a new 52-week low of $1.08 on Thursday. Shares of the company traded down 52.6%.
    • Taoping (NASDAQ:TAOP) stock hit a yearly low of $0.51. The stock was down 8.77% for the day.
    • T Stamp (NASDAQ:IDAI) stock hit $1.04 on Thursday morning, setting a new 52-week low for a change of down 8.74%.
    • Greenwave Tech Solns (NASDAQ:GWAV) shares were down 6.25% for the day, having made a 52-week low of $0.73.
    • Biophytis (NASDAQ:BPTS) shares set a new 52-week low of $2.13. The stock traded up 0.86%.
    • Ault Alliance (AMEX:AULT) stock achieved a new 52-week low on Thursday morning, hitting $5.00 and moving down 0.38%.
    • Diffusion Pharmaceuticals (NASDAQ:DFFN) shares fell to $2.88 on Thursday, setting a new 52-week low with a shift of down 4.93%.
    • Revelation Biosciences (NASDAQ:REVB) shares were down 11.59% for the day, having made a 52-week low of $0.80.
    • Galmed Pharmaceuticals (NASDAQ:GLMD) stock achieved a new 52-week low on Thursday morning, hitting $2.65 and moving down 5.08%.
    • Altamira Therapeutics (NASDAQ:CYTO) shares reached a new 52-week low of $0.46 on Thursday morning, moving down 6.61%.
    • Akerna (NASDAQ:KERN) stock achieved a new 52-week low on Thursday morning, hitting $0.53 and moving down 5.07%.
    • Eightco Holdings (NASDAQ:OCTO) stock dropped to a yearly low on Thursday of $1.32. Shares traded down 4.42%.
    • Save Foods (NASDAQ:SVFD) stock hit a new 52-week low of $0.51. The stock was up 4.29% on the session.
    • Esports Entertainment (NASDAQ:GMBL) stock set a new 52-week low of $1.03 on Thursday, moving down 4.54%.
    • Blue Star Foods (NASDAQ:BSFC) shares moved down 0.92% on Thursday to hit a new 52-week low of $1.06, drifting down 0.92%.
    • Eastside Distilling (NASDAQ:EAST) shares were up 0.98% for the day, having made a 52-week low of $3.00.
    • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares fell to $4.11 on Thursday, setting a new 52-week low with a shift of down 0.65%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $VRAY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VRAY
    $WIA
    $WIW
    $XNCR

    CompanyDatePrice TargetRatingAnalyst
    Repligen Corporation
    $RGEN
    4/17/2026$160.00Buy
    Rothschild & Co Redburn
    Southside Bancshares Inc.
    $SBSI
    4/15/2026$35.00Neutral
    Piper Sandler
    Jazz Pharmaceuticals plc
    $JAZZ
    4/10/2026$227.00Outperform
    Raymond James
    Nasdaq Inc.
    $NDAQ
    4/8/2026$92.00Mkt Perform
    Keefe Bruyette
    Dine Brands Global Inc.
    $DIN
    4/3/2026Overweight → Sector Weight
    KeyBanc Capital Markets
    Dine Brands Global Inc.
    $DIN
    4/2/2026Overweight → Sector Weight
    KeyBanc Capital Markets
    Vor Biopharma Inc.
    $VOR
    3/30/2026$50.00Buy
    Jefferies
    Xencor Inc.
    $XNCR
    3/24/2026$13.00Overweight → Neutral
    Analyst
    More analyst ratings

    $VRAY
    $WIA
    $WIW
    $XNCR
    SEC Filings

    View All

    SEC Form RW filed by Nuburu Inc.

    RW - Nuburu, Inc. (0001814215) (Filer)

    4/23/26 5:13:40 PM ET
    $BURU
    Industrial Machinery/Components
    Miscellaneous

    SEC Form DEFA14A filed by ClearPoint Neuro Inc.

    DEFA14A - ClearPoint Neuro, Inc. (0001285550) (Filer)

    4/23/26 5:08:22 PM ET
    $CLPT
    Medical/Dental Instruments
    Health Care

    SEC Form DEFA14A filed by Nkarta Inc.

    DEFA14A - Nkarta, Inc. (0001787400) (Filer)

    4/23/26 4:41:50 PM ET
    $NKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $VRAY
    $WIA
    $WIW
    $XNCR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Investment Officer Evans Julian to cover withholding tax

    4 - Cherry Hill Mortgage Investment Corp (0001571776) (Issuer)

    4/23/26 4:05:23 PM ET
    $CHMI
    Real Estate Investment Trusts
    Real Estate

    SEC Form 4 filed by President and CEO Lown Jeffrey B (for tax liability)

    4 - Cherry Hill Mortgage Investment Corp (0001571776) (Issuer)

    4/23/26 4:05:23 PM ET
    $CHMI
    Real Estate Investment Trusts
    Real Estate

    SEC Form 4 filed by Chief Financial Officer Patel Apeksha to satisfy withholding obligation

    4 - Cherry Hill Mortgage Investment Corp (0001571776) (Issuer)

    4/23/26 4:05:22 PM ET
    $CHMI
    Real Estate Investment Trusts
    Real Estate

    $VRAY
    $WIA
    $WIW
    $XNCR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rothschild & Co Redburn initiated coverage on Repligen with a new price target

    Rothschild & Co Redburn initiated coverage of Repligen with a rating of Buy and set a new price target of $160.00

    4/17/26 8:13:33 AM ET
    $RGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Piper Sandler resumed coverage on Southside Banc with a new price target

    Piper Sandler resumed coverage of Southside Banc with a rating of Neutral and set a new price target of $35.00

    4/15/26 8:10:14 AM ET
    $SBSI
    Major Banks
    Finance

    Raymond James resumed coverage on Jazz Pharma with a new price target

    Raymond James resumed coverage of Jazz Pharma with a rating of Outperform and set a new price target of $227.00

    4/10/26 12:21:53 PM ET
    $JAZZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $VRAY
    $WIA
    $WIW
    $XNCR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

    For Immediate Release: November 14, 2024 The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency. “Clinical advancements in the f

    11/14/24 8:50:18 AM ET
    $CLPT
    $PTCT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $VRAY
    $WIA
    $WIW
    $XNCR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Pasquale Douglas M bought $27,750 worth of shares (1,000 units at $27.75) (SEC Form 4)

    4 - Dine Brands Global, Inc. (0000049754) (Issuer)

    3/16/26 8:55:41 PM ET
    $DIN
    Restaurants
    Consumer Discretionary

    Chief Legal Officer-Healthcare Montgomery Pamela W. bought $7,021 worth of shares (79 units at $88.87), increasing direct ownership by 3% to 2,758 units (SEC Form 4)

    4 - Nutex Health Inc. (0001479681) (Issuer)

    3/16/26 3:02:43 PM ET
    $NUTX
    Real Estate

    Director Pasquale Douglas M bought $85,500 worth of shares (3,000 units at $28.50) (SEC Form 4)

    4 - Dine Brands Global, Inc. (0000049754) (Issuer)

    3/12/26 8:05:36 PM ET
    $DIN
    Restaurants
    Consumer Discretionary

    $VRAY
    $WIA
    $WIW
    $XNCR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SoundThinking Announces First Quarter 2026 Financial Results Date and Conference Call

    FREMONT, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- SoundThinking, Inc. (NASDAQ:SSTI) ("SoundThinking" or the "Company"), a leading public safety technology company, today announced the date for the release of its financial results for the first quarter ended March 31, 2026. SoundThinking will release its first quarter 2026 financial results after the market closes on Thursday, May 14, 2026. The Company will host a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) on that day to discuss its financial results and outlook. Those wishing to participate via webcast should access the call through SoundThinking's Investor Relations website at ir.soundthinking.

    4/23/26 4:05:00 PM ET
    $SSTI
    Computer Software: Prepackaged Software
    Technology

    Trust Stamp and Partisia partner with Digital Platformer to Combine Biometric Tokenisation and MPC Technologies to Advance Decentralised Identity Solutions in Japan and the Region

    Atlanta, GA, April 23, 2026 (GLOBE NEWSWIRE) -- Trust Stamp (NASDAQ:IDAI), the Privacy-First Identity Company™, with the participation of Partisia, a pioneer in secure Multi-Party Computation (MPC), has signed a commercial agreement with Digital Platformer, a leader in decentralised solutions, to deploy and develop technologies that advance financial security, identity verification, and privacy protection across Japan's financial services sector and the wider region.Japan is continuing to make steady progress in its digital transformation, with organizations across sectors such as financial services, insurance, healthcare, and government working to modernize their systems and enhance digit

    4/23/26 9:30:00 AM ET
    $IDAI
    Computer Software: Prepackaged Software
    Technology

    22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State University

    MOCKSVILLE, N.C., April 23, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), a tobacco products company focused on nicotine reduction and plant biotechnology, today announced corporate updates regarding a new testing services agreement with North Carolina State University aimed at validating tobacco varieties featuring improved leaf quality and increased crop yields with the same low-nicotine content. The initiative builds upon 22nd Century's proprietary reduced nicotine content technology platform, which utilizes advanced plant breeding and biotechnology to reduce nicotine content in tobacco to minimally addictive levels. The Company's reduced nicotine tobacco is the foun

    4/23/26 7:50:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $VRAY
    $WIA
    $WIW
    $XNCR
    Leadership Updates

    Live Leadership Updates

    View All

    Sandisk Corporation to Join the Nasdaq-100 Index® Beginning April 20, 2026

    NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Sandisk Corporation (NASDAQ:SNDK) will become a component of the Nasdaq-100 Index® (NDX®) replacing Atlassian Corporation (NASDAQ:TEAM) prior to market open on Monday, April 20, 2026. These updates are consistent with the current Nasdaq-100 Index® methodology, in effect through April 30, 2026. For additional information, including notifications on changes to any Nasdaq Indexes, please go to https://indexes.nasdaq.com/ About Nasdaq Global Indexes Nasdaq Global Indexes is one of the world's leading index providers, offering a comprehensive suite of rules-based benchmarks and indexes. The Nasdaq-100 Inde

    4/10/26 8:00:00 PM ET
    $NDAQ
    $SNDK
    $TEAM
    Investment Bankers/Brokers/Service
    Finance
    Electronic Components
    Technology

    BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer

    — Experienced R&D leader with a track record of advancing innovative therapies from early development to global approval —  RESEARCH TRIANGLE PARK, N.C., April 06, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced the appointment of Sandeep M. Menon, MD, PhD, as Chief Research and Development Officer. Building on the commercial success of ORLADEYO® and the recent acquisition of Astria Therapeutics and the navenibart program, BioCryst is entering a new phase of execution in its strategy to build value through development and commercialization of rare disease therapies. Dr. Menon joins BioCryst from Alnylam Pharmaceuticals, where he served as Chief Devel

    4/6/26 7:00:00 AM ET
    $BCRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Preliminary Results for the Year Ended 31 December 2025

    March 27, 2026 Biodexa Pharmaceuticals PLC("Biodexa" or the "Company" or, together with its subsidiaries, the "Group") Preliminary Results for the Year Ended 31 December 2025 Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), a clinical-stage biopharmaceutical company developing innovative products focused on the treatment or prevention of gastrointestinal cancers, announces its audited preliminary results for the year ended 31 December 2025. For more information, please contact: Biodexa Pharmaceuticals PLC Stephen Stamp, CEO Fiona Sharp, CFOTel: +44 (0)29 2048 0180www.biodexapharma.com About Biodexa The Company's lead development programs include eRapa, under development for Familial Adenoma

    3/27/26 5:00:00 PM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $VRAY
    $WIA
    $WIW
    $XNCR
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at Monopar Therapeutics Inc. on Jun 21 Indicate?

    Monopar Therapeutics Inc. has recently seen notable insider activity, with Chief Operating Officer Cittadine Andrew purchasing $25,574 worth of shares on June 21st, 2024. This purchase, comprising 32,508 units at $0.79, increased Cittadine's direct ownership by 21% to 186,132 units as reported in the SEC Form 4. When analyzing this transaction alongside other recent insider activities within the company, interesting patterns and trends start to emerge. Looking back, Cittadine Andrew has been consistently adding to his position in Monopar Therapeutics Inc. over the past few months, showcasing a strong conviction in the company's future prospects. On May 31st, Cittadine Andrew made a substan

    6/22/24 8:00:00 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $VRAY
    $WIA
    $WIW
    $XNCR
    Financials

    Live finance-specific insights

    View All

    SoundThinking Announces First Quarter 2026 Financial Results Date and Conference Call

    FREMONT, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- SoundThinking, Inc. (NASDAQ:SSTI) ("SoundThinking" or the "Company"), a leading public safety technology company, today announced the date for the release of its financial results for the first quarter ended March 31, 2026. SoundThinking will release its first quarter 2026 financial results after the market closes on Thursday, May 14, 2026. The Company will host a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) on that day to discuss its financial results and outlook. Those wishing to participate via webcast should access the call through SoundThinking's Investor Relations website at ir.soundthinking.

    4/23/26 4:05:00 PM ET
    $SSTI
    Computer Software: Prepackaged Software
    Technology

    Nasdaq Announces Increase in Quarterly Dividend to $0.31 Per Share

    NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Nasdaq, Inc. (NASDAQ:NDAQ) has declared a regular quarterly dividend of $0.31 per share on the company's outstanding common stock. The dividend is payable on June 26, 2026 to shareholders of record at the close of business on June 12, 2026. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to approval by the Board of Directors. About NasdaqNasdaq (NASDAQ:NDAQ) is a leading technology platform that powers the world's economies. We architect the infrastructure of the world's most modern markets, power the innovation economy, and build trust in the financial

    4/23/26 7:01:00 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Nasdaq Reports First Quarter 2026 Results; Strong Execution Drives Double-Digit Net Revenue Growth Across All Divisions

    NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (NASDAQ:NDAQ) today reported financial results for the first quarter of 2026. First quarter 2026 net revenue1 was $1.4 billion, an increase of 14% over the first quarter of 2025, or 13% on an organic2 basis. Solutions revenue3 grew 14% on both a reported and organic basis.Annualized Recurring Revenue (ARR)3,4 of $3.2 billion increased 13% on a reported basis over the first quarter of 2025, or 12% on an organic basis. Annualized SaaS revenue increased 13%, or 16% on an organic basis, and represented 38% of ARR.Financial Technology revenue was $517 million, an increase of 20% over the first quarter of 2025, or 18% on an organic basis

    4/23/26 7:00:00 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    $VRAY
    $WIA
    $WIW
    $XNCR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Monopar Therapeutics Inc.

    SC 13D/A - Monopar Therapeutics (0001645469) (Subject)

    12/17/24 5:01:42 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by MSP Recovery Inc.

    SC 13D/A - MSP Recovery, Inc. (0001802450) (Subject)

    12/17/24 4:05:04 PM ET
    $LIFW
    EDP Services
    Technology

    SEC Form SC 13G filed by Nkarta Inc.

    SC 13G - Nkarta, Inc. (0001787400) (Subject)

    12/13/24 5:02:47 PM ET
    $NKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care